Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Autonomix Medical Inc AMIX

Healthcare Medical Devices
Autonomix Medical, Inc. is a medical device company, which is focused on advancing technologies to treat diseases involving the peripheral nervous system. Its technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times sensitivity. It is developing a two-fold technology that can both... see more

Recent & Breaking News (NDAQ:AMIX)

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering

GlobeNewswire 1 day ago

Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

GlobeNewswire 12 days ago

Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients' 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction

GlobeNewswire October 31, 2024

Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial

GlobeNewswire October 30, 2024

Positive Preliminary Results Demonstrate Autonomix's Proprietary RF Ablation Technology's Ability to Reduce Opioid Use in Ongoing Human Clinical Trial

GlobeNewswire October 28, 2024

Autonomix Medical, Inc. to Participate in a Virtual Investor "What This Means" Segment on Wednesday, October 30th

GlobeNewswire October 25, 2024

Autonomix Announces Reverse Stock Split

GlobeNewswire October 22, 2024

Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC

GlobeNewswire October 8, 2024

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

GlobeNewswire September 26, 2024

Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum

GlobeNewswire September 20, 2024

Autonomix Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients

GlobeNewswire September 9, 2024

Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire August 27, 2024

Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress

GlobeNewswire August 21, 2024

Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones

GlobeNewswire August 13, 2024

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

GlobeNewswire August 2, 2024

Autonomix Completes Licensing Transaction for FDA-Cleared Ablation Technology

GlobeNewswire July 24, 2024

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

GlobeNewswire July 22, 2024

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor "What This Means" Segment Covering Technology License Agreement

GlobeNewswire July 18, 2024

Autonomix Enters into Definitive Agreement to License Intellectual Property for FDA-Cleared Ablation Technology from RF Innovations, Inc.

GlobeNewswire July 15, 2024

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Launch of CEO Corner Platform

GlobeNewswire July 11, 2024